Literature DB >> 155647

Use of stimulating capacity of mixed lymphocyte reaction (MLR-S) as a possible marker for the cell-origin of null-cell acute lymphoblastic leukaemia.

T Han, J Minowada.   

Abstract

The recent introduction of surface marker analysis indicates that the T-cell ALL represents 15--25%, the B-cell ALL represents less than 5% and the null-cell ALL represents more than 70% of cases. The origin of leukaemic null-cells is at present not clear. The present study shows that fresh leukaemic cells from five patients with null-cell ALL exerted a strong stimulating effect while the leukaemic cells from three patients with null-cell ALL failed to stimulate in 'one-way' MLR. Cultured leukaemic cells from three null-cell lines (NALM-16, NALL-1 and MOLT-10) consistently exerted a strong stimulation while leukaemic cells from one null-cell line (REH) exerted little or no stimulation on allogeneic lymphocytes. Leukaemic null-cells from the NALM-,6 line exhibited a lesser but significant stimulation in 'one-way' MLR. These observations lead us to speculate that leukaemic null-cells which possess a stimulating capacity may represent less differentiated leukaemic B lymphoid cells (early B-cell precursors) and leukaemic null-cells which possess no stimulating capacity may represent less differentiated leukaemic T lymphoid cells (early T-cell precursor).

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 155647      PMCID: PMC1457255     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Antisera to acute lymphoblastic leukemia cells.

Authors:  M F Greaves; G Brown; N T Rapson; T A Lister
Journal:  Clin Immunol Immunopathol       Date:  1975-05

2.  Editorial: Unmasking the heterogeneity of acute lymphoblastic leukemia.

Authors:  E W Gelfand; B E Chechik
Journal:  N Engl J Med       Date:  1976-01-29       Impact factor: 91.245

3.  Stimulating capacity of fresh and cultured human leukaemic lymphoid and myeloid cells in 'one-way' mixed lymphocyte reaction.

Authors:  T Han; B Dadey; J Minowada
Journal:  Immunology       Date:  1977-10       Impact factor: 7.397

4.  Phenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line.

Authors:  C Rosenfeld; A Goutner; C Choquet; A M Venuat; B Kayibanda; J L Pico; M F Greaves
Journal:  Nature       Date:  1977-06-30       Impact factor: 49.962

5.  Human B cell, T cell and null cell leukaemic cell lines derived from acute lymphoblastic leukaemias.

Authors:  I Miyoshi; S Hiraki; T Tsubota; I Kubonishi; Y Matsuda; T Nakayama; H Kishimoto; I Kimura; H Masuji
Journal:  Nature       Date:  1977-06-30       Impact factor: 49.962

6.  T and B lymphocytes. Exclusive role as responders and stimulators in human one-way mixed lymphocyte reaction.

Authors:  T Han; B Dadey
Journal:  Immunology       Date:  1976-10       Impact factor: 7.397

7.  Distribution of Ia-like molecules on the surface of normal and leukemic human cells.

Authors:  S F Schlossman; L Chess; R E Humphreys; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

8.  Disparity of mixed lymphocyte reactivity to cultured cells of human T and B lymphoid lines.

Authors:  J L Pauly; J Minowada; T Han; G E Moore
Journal:  J Natl Cancer Inst       Date:  1975-03       Impact factor: 13.506

9.  Clinical importance of lymphoblasts with T markers in childhood acute leukemia.

Authors:  L Sen; L Borella
Journal:  N Engl J Med       Date:  1975-04-17       Impact factor: 91.245

10.  The occurrence of the HL-B alloantigens on the cells of unclassified acute lymphoblastic leukemias.

Authors:  S M Fu; R J Winchester; H G Kunkel
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

View more
  3 in total

1.  Expression of Pax5 gene in human haematopoietic cells and tissues: comparison with immunodeficient donors.

Authors:  H Kaneko; T Ariyasu; R Inoue; T Fukao; K Kasahara; T Teramoto; E Matsui; S Hayakawa; N Kondo
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

2.  An HLA-DR negative acute leukaemia which stimulates MLC and CMC responses.

Authors:  G M Taylor; W Fergusson; P A Dyer; R Harris; G Morrell
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

3.  Lack of correlation between lymphocyte activating determinants and HLA-DR on acute leukaemias.

Authors:  G M Taylor; J C Ridway; W D Fergusson; R Harris
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.